Tim Scott currently serves as President and CEO of AustinPx since April 2022, while also holding the position of Chairman of the Board and CEO at TEGA Therapeutics, Inc., a role established in 2014. Additionally, Tim Scott has been Chairman of the Board for Biocom California since March 2010 and a member of the Board of Trustees at the University of San Diego since August 2022. Involvement extends to various boards, including Avelas Biosciences, Inc. and DTxPharma, among others. Tim Scott’s educational background includes a Bachelor of Arts in Biochemistry from UC San Diego and a Juris Doctor from the University of San Diego School of Law.